AI-powered glucose analysis: GPT-4 offers promise with room for refinement

GPT-4 demonstrates its potential in analyzing continuous glucose monitoring data, offering accurate metrics and summaries while highlighting areas for refinement in diabetes care.

Opinion | Neurotechnology Development Must Be Slow and Steady

Murray is a neuroscientist and post-doctoral fellow. Through my work as a neuroscientist who designs neural implants to monitor the injured brain after severe traumatic

April 23, 2024

Future drug makers can develop their skills using virtual reality at new national Centre of Excellence

Future medicine and vaccine makers will be able to develop their skills using virtual reality at a new national Centre of Excellence, after a successful

March 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

AI-powered glucose analysis: GPT-4 offers promise with room for refinement

Aptamer and Timser partner to deliver world’s first blood test for cervical cancer

Opinion | Neurotechnology Development Must Be Slow and Steady

Future drug makers can develop their skills using virtual reality at new national Centre of Excellence

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe